Disclosures for "Povetacicept (ALPN-303), a Potent Dual BAFF/APRIL Antagonist, Suppresses Disease in a Mouse Model of Autoimmune Encephalitis"
-
Katherine E. Lewis, PhD has received personal compensation for serving as an employee of Alpine Immune Sciences. Katherine E. Lewis, PhD has stock in Alpine Immune Sciences.
-
Dr. MARIA has received personal compensation for serving as an employee of Alpine Immune Sciences. Dr. MARIA has stock in Alpine Immune Sciences.
-
Ms. Griffin has received personal compensation for serving as an employee of Alpine Immune Sciences. Ms. Griffin has stock in Alpine Immune Sciences.
-
Mr. Lenox has received personal compensation for serving as an employee of Alpine Immune Sciences. Mr. Lenox has received personal compensation in the range of $50,000-$99,999 for serving as a Senior Research Associate with Altius Institute for Biomedical Research.
-
Miss Wang has nothing to disclose.
-
Stacey Dillon has received personal compensation for serving as an employee of Alpine Immune Sciences. Stacey Dillon has stock in Alpine Immune Sciences. Stacey Dillon has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Peng has received personal compensation for serving as an employee of Alpine Immune Sciences.